Modelon AB (publ)
F:3VM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Modelon AB (publ)
F:3VM
|
SE |
|
Nuformix PLC
F:1RT
|
UK |
|
Marinomed Biotech AG
F:93Z
|
AT |
|
I
|
ICON PLC
F:IJF
|
IE |
|
Marvel Gold Ltd
F:GR2
|
AU |
|
D
|
DevvStream Corp
OTC:DEVSF
|
US |
|
P
|
Probiotec Ltd
XBER:PG3
|
AU |
|
H
|
Hirose Electric Co Ltd
F:HRO
|
JP |
|
Gusbourne PLC
F:S8E
|
UK |
|
Zueblin Immobilien Holding AG
F:61Z
|
CH |
|
Aion Therapeutic Inc
OTC:ANTCF
|
CA |
|
Fast Finance 24 Holding AG
F:FF24
|
DE |
Wall St Price Targets
3VM Price Targets Summary
Modelon AB (publ)
According to Wall Street analysts, the average 1-year price target for 3VM is 1.225 EUR with a low forecast of 1.213 EUR and a high forecast of 1.261 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 3VM's stock price target?
Price Target
1.225
EUR
According to Wall Street analysts, the average 1-year price target for 3VM is 1.225 EUR with a low forecast of 1.213 EUR and a high forecast of 1.261 EUR.
What is the Revenue forecast for Modelon AB (publ)?
Projected CAGR
36%
Over the last 3 years, the compound annual growth rate for Revenue has been -11%. The projected CAGR for the next 2 years is 36%.